Marcus Vinicius Sadi
Research Subjects
Research Interests
Marcus Vinicius Sadi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Antônio Carlos Lima Pompeo
Comitê Brasileiro de Estudos em Uro-Oncologia (CoBEU), São Paulo, Brazil
1 shared publication - Francisco Flávio Horta Bretas
Comitê Brasileiro de Estudos em Uro-Oncologia (CoBEU), São Paulo, Brazil
1 shared publication - Otávio Clark
Evidências‐ A Kantar Health Company R Tranquillo Prosperi, 143 Campinas São Paulo Brazil 13084‐778
1 shared publication - Rodolfo Borges dos Reis
Department of Surgery and Anatomy, Urology Division Ribeirao Preto School of Medicine, University of Sao Paulo Ribeirao Preto Sao Paulo Brazil
1 shared publication - Tobias Engel Ayer Botrel
Affiliations: Evidencias - A Kantar Health Company, Campinas, São Paulo, Brazil, Comitê Brasileiro de Estudos em Uro-Oncologia - CoBEU, São Paulo, São Paulo, Brazil
1 shared publication - Ubirajara Ferreira
Clinical Hospital of Unicamp, Campinas 13083-888, SP, Brazil
1 shared publication
Latest Publications
- Open Access
- 25 January 2014
- Published by Springer Nature in BMC Urology
- Vol. 14 (1) , 9
Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis
Prostate cancer is the most common cancer in older men in the United States (USA) and Western Europe. Androgen deprivation (AD) constitutes, in most cases, the first-line of treatment for these cases. The negative impact of CAD in quality of life, secondary to the adverse events of sustained hormone deprivation, plus the costs of this therapy, motivated the intermittent treatment approach. The objective of this study is to to perform a systematic review and meta-analysis of all randomized controlled trials that compared the efficacy and adverse events profile of intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic hormone-sensitive prostate cancer.
- 25 January 2014
- Published by Springer Nature in BMC Urology
- Vol. 14 (1) , 9
Open AccessIntermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis
Prostate cancer is the most common cancer in older men in the United States (USA) and Western Europe. Androgen deprivation (AD) constitutes, in most cases, the first-line of treatment for these cases. The negative impact of CAD in quality of life, secondary to the adverse events of sustained hormone deprivation, plus the costs of this therapy, motivated the intermittent treatment approach. The objective of this study is to to perform a systematic review and meta-analysis of all randomized controlled trials that compared the efficacy and adverse events profile of intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic hormone-sensitive prostate cancer.